Spero logo

Spero

spero.vc

VCMatch tracks Spero as an investor focused on Digital Health, Biotech, and Medtech companies, Seed and Series A rounds, United States markets, and $2m to $4m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$2m to $4m

Stages

Seed, Series A

Geography

United States

Investment Thesis

Spero Ventures is a mission-driven early-stage investor that backs founders using technology to tackle large, societally important problems. They prioritize purpose-led companies where “mission is an accelerant and a strategic advantage,” and pair that conviction with a focus on sustained, high-quality execution and close operational support from a team of former builders and operators.

Is Spero right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

Investment Focus

Who should take a closer look

Spero is most relevant for founders raising Seed and Series A rounds in Digital Health, Biotech, Medtech, and Pharma, especially across United States, with public check-size signals around $2m to $4m.

Focus statement

Spero invests in companies improving human health and longevity, upgrading planet-critical systems (water, food, energy, transportation, manufacturing, waste), and new technologies that change how we create, learn, and work; they lead and co-lead seed and Series A rounds (funds $3–$10M; initial checks typically $2–$4M).

Value Add

  • Operator-heavy team with direct scaling experience at Tesla, Stripe, and eBay and early bets in Carta, Tumblr, and Turo (site lists these companies as experience/portfolio).
  • Concentrated portfolio approach enabling deep, hands-on engagement: "allows us to engage deeply with our founders, building meaningful, long-lasting relationships rooted in trust and shared goals."
  • Explicit, measurable stage and check-sizing (lead/co-lead seed & Series A; typical initial check $2–$4M with reserves), giving founders clarity on capital strategy.
  • Deliberate focus on diversity and closing the Series A funding gap for underrepresented founders—committed to investing earlier (seed) and providing operational resources to help clear Series A bar.
  • Practical, operational support offerings: on-call guidance, office hours, product/design sprints, lean canvases, and introductions to early-stage experts.

Stage And Sector Fit

Portfolio Highlights

Allie Systems

Unknown

Anchor

Unknown

Aralez Bio

Biotech

Base Operations

Unknown

Biomilq

Biotech

Bunker

Unknown

Canopy

Unknown

Clarity

Unknown

+ 49 more companies in their portfolio